MediciNova, Inc. (MNOV)
2.08
-0.50
(-19.38%)
USD |
NASDAQ |
Sep 28, 16:00
2.08
0.00 (0.00%)
After-Hours: 16:43
MediciNova Research and Development Expense (TTM) : 5.357M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.357M |
| March 31, 2026 | 6.517M |
| December 31, 2025 | 7.093M |
| September 30, 2025 | 7.456M |
| June 30, 2025 | 7.775M |
| March 31, 2025 | 7.232M |
| December 31, 2024 | 7.174M |
| September 30, 2024 | 6.917M |
| June 30, 2024 | 5.852M |
| March 31, 2024 | 5.892M |
| December 31, 2023 | 5.539M |
| September 30, 2023 | 5.858M |
| June 30, 2023 | 7.469M |
| March 31, 2023 | 8.292M |
| December 31, 2022 | 8.931M |
| September 30, 2022 | 8.737M |
| June 30, 2022 | 8.419M |
| March 31, 2022 | 8.435M |
| December 31, 2021 | 8.512M |
| September 30, 2021 | 8.533M |
| June 30, 2021 | 8.684M |
| March 31, 2021 | 8.357M |
| December 31, 2020 | 7.464M |
| September 30, 2020 | 7.495M |
| June 30, 2020 | 6.408M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.679M |
| December 31, 2019 | 6.067M |
| September 30, 2019 | 4.459M |
| June 30, 2019 | 5.684M |
| March 31, 2019 | 5.598M |
| December 31, 2018 | 5.626M |
| September 30, 2018 | 6.569M |
| June 30, 2018 | 5.467M |
| March 31, 2018 | 4.985M |
| December 31, 2017 | 4.224M |
| September 30, 2017 | 3.658M |
| June 30, 2017 | 3.279M |
| March 31, 2017 | 3.344M |
| December 31, 2016 | 3.519M |
| September 30, 2016 | 3.841M |
| June 30, 2016 | 3.538M |
| March 31, 2016 | 3.373M |
| December 31, 2015 | 3.017M |
| September 30, 2015 | 2.886M |
| June 30, 2015 | 3.193M |
| March 31, 2015 | 3.232M |
| December 31, 2014 | 3.260M |
| September 30, 2014 | 3.415M |
| June 30, 2014 | 3.307M |
| March 31, 2014 | 3.418M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Viking Therapeutics, Inc. | 509.32M |
| IDEAYA Biosciences, Inc. | 374.01M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| Alnylam Pharmaceuticals, Inc. | 1.509B |